Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.

Aurora Cannabis Inc (ACB) reports significant revenue increases and maintains a robust cash position, despite challenges in ...

Despite reporting better-than-expected revenue for Q1 fiscal 2026, Aurora Cannabis (NASDAQ:ACB) traded ~9% lower after the ...

Greetings and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call all participants will ...

ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a ...

Aurora Cannabis ( ($TSE:ACB) ) has issued an announcement. Aurora Cannabis Inc. announced the results of its 2025 Annual General and Special ...

We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Aurora Cannabis Inc. stands fourth on ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Last quarter, Aurora Cannabis reported just a 5% increase in its top line, compared to the prior-year period, with sales climbing to CA$67.4 million.

Medical-cannabis net revenue in the most recent quarter, which ended on Sept. 30, totaled 43.8 million Canadian dollars ($32.3 million), which was nearly four times Aurora's consumer-cannabis net ...

Shares of Aurora Cannabis reached a low of $0.60 on March 18, 2020. If you invested $15,000 in the stock back then, you would have owned 25,000 shares of the cannabis company -- until its reverse ...